10.14
price down icon8.57%   -0.95
after-market Dopo l'orario di chiusura: 10.89 0.75 +7.40%
loading

Tempest Therapeutics Inc Azioni (TPST) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Operating Income/Loss
27.16%
-7.966
-10.94 -13.92 -10.55 -9.582
Nonoperating Income/Loss
26.32%
0.096
0.076 0.105 -0.005 0.012
Income/Loss From Continuing Operations Before Tax
27.53%
-7.87
-10.86 -13.81 -10.56 -9.57
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
27.53%
-7.87
-10.86 -13.81 -10.56 -9.57
Net Income/Loss
27.53%
-7.87
-10.86 -13.81 -10.56 -9.57
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
10.63%
3.803
3.4377 4.3643 25.81 22.55
Diluted Average Shares
10.63%
3.803
3.4377 4.3643 25.81 22.55
Basic Earnings Per Share
34.49%
-2.07
-3.16 -0.31 -0.41 -0.42
Diluted Earnings Per Share
34.49%
-2.07
-3.16 -0.31 -0.41 -0.42
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$37.01
price up icon 1.84%
$87.57
price up icon 0.30%
$33.17
price up icon 1.28%
$105.14
price up icon 0.06%
biotechnology ONC
$316.42
price down icon 0.50%
$165.76
price up icon 1.57%
Capitalizzazione:     |  Volume (24 ore):